Inhaled opioids for the treatment of dyspnea

American Journal of Health-System Pharmacy

Volumn 62, Issue 3, 2005, Pages 319-320

  Ferraresi, Victoria ^a  

^a Pathways Home Health and Hospice   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL CITRATE; HYDROMORPHONE; MORPHINE; MORPHINE SULFATE; OPIATE;

BRONCHOSPASM; CONSTIPATION; DRUG BIOAVAILABILITY; DRUG COST; DRUG MECHANISM; DYSPNEA; HUMAN; NAUSEA; PRIORITY JOURNAL; RELAXATION TRAINING; SEDATION; SHORT SURVEY; SIDE EFFECT; VOMITING;

EID: 15544374875     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/62.3.319     Document Type: Short Survey

References (14)

1. Beers MH, Berkow R, eds. Pulmonary disorders: dyspnea. In: The Merck manual of diagnosis and therapy. 17th ed. www.merck.com/mrkshared/mmanual/ section6/chapter63/63c.jsp (accessed 2004 May 30).
2. Dudgeon DJ, Rosenthal S. Management of dyspnea and cough in patients with cancer. Hematol Oncol Clin North Am. 1996; 10:157-71.
3. Gutstein HB, Akil H. Opioid analgesics. In: Hardman JG, Limbird LE, Gilman AG, eds. Goodman & Gilman's the pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill; 2001:569-619.
4. Zebraski SE, Kochenash SM, Raffa RB. Lung opioid receptors: pharmacology and possible target for nebulized morphine in dyspnea. Life Sci. 2000; 66:2221-31.
5. Masood AR, Thomas SH. Systemic absorption of nebulized morphine compared with oral morphine in healthy subjects. Br J Clin Pharmacol. 1996; 41:250-2.
6. Chrubasik J, Wust H, Friedrich G et al. Absorption and bioavailability of nebulized morphine. Br J Anaesth. 1988; 61:228-30.
7. Masood AR, Subham MM, Reed JW et al. Effects of inhaled nebulized morphine on ventilation and breathlessness during exercise in healthy man. Clin Sci. 1995; 88:447-52.
8. Masood AR, Reed JW, Thomas SH. Lack of effect of inhaled morphine on exercise-induced breathlessness in chronic obstructive pulmonary disease. Thorax. 1995; 50:629-34.
9. Leung R, Hill P, Burdon J. Effect of inhaled morphine on the development of breathlessness during exercise in patients with chronic lung disease. Thorax. 1996; 51:596-600.
10. Beauford W, Saylor TT, Stansbury DW et al. Effects of nebulized morphine sulfate on the exercise tolerance of the ventilatory limited COPD patient. Chest. 1993; 104:175-8.
11. Jennings AL, Davies AN, Higgins JP et al. Opioids for the palliation of breathlessness in terminal illness. Cochrane Database Syst Rev. 2001; 4:CD002066.
12. Lang E, Jedeikin R. Acute respiratory depression as a complication of nebulized morphine. Can J Anaesth. 1998; 45:60-2.
13. Carney MT, Meier DE. Geriatric anesthesia: palliative care and end-of-life issues. Anesthesiol Clin North Am. 2000; 18(1):183-209.
14. Coyne PJ. The use of nebulized fentanyl for the management of dyspnea. Clin J Oncol Nurs. 2003; 7:334-5.